In accordance, administration of exogenous IL-18 counteracted steatohepatitis in mice on HFD (66) while IL-18-/- mice exhibited hepatic steatosis, insulin resistance, increased expression of gluconeogenic genes and defective phosphorylation of STAT3 (26). The gene discussed is IL18; the disease is Hepatic steatosis.